Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Course Radiotherapy Followed by FOLFOX for Rectal Cancer
NCT01060007Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2009
- Primary completion
- Apr 2013
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in rectal cancer, sponsored by Washington University School of Medicine. Started Nov 2009; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01060007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060007.